RB1 and neuroblastoma: For instance, the outcome of NB patients has been revealed to be associated with varying molecular signatures, including genetic mutations of specific genes (48), the methylation status of RB1 and TDGF1 (49), detectable circulating tumor DNAs in blood biopsy (50), and altered mRNA expression levels of specific gene lists (51–54).